ՕԳՏԱԳՈՐԾՎԱԾ   ԳՐԱԿԱՆՈւԹՅԱՆ  ՑԱՆԿ

1.  Anjali, Dharampal Pathak and Divya Singh. Quinoline: a diverse therapeutic agent. Anjali et al., IJPSR, 2016; 7(1): 1-13. doi: http://dx.doi.org/10.13040/IJPSR.0975-8232.7
2. Chibale, K., Moss, J.R., Blackie, M., Schalkwyk, D., Smith, P.J. New amine and urea analogs of ferrochloroquine: synthesis, antimalarial activity in vitro and electrochemical studies. Tetrahedron Lett. 2000;41(32):6231–6235. doi: https://doi.org/10.1016/S0040-4039(00)01036-4
3. Mahajan, A., Yeh, S., Nell, M., Rensburg, C.E.J., Chibale, K. Synthesis of new 7-chloro­quinolinyl thioureas and their biological investigation as potential anti-malarial and anticancer agents. Bioorg. Med. Chem. Lett. 2007;17(20):5683–5685. doi:https://doi.org/­10.1016/­j.bmcl.2007.07.049
4. Huo, Z., Gridnev, I.D., Yamamoto, Y. A method for thesynthesis of substituted quinolines via electrophilic cyclization of 1-azido-2-(2-propynyl) benzene. J. Org Chem. 2010;75(4):1266–1270. doi: https://doi.org/10.1021/jo902603v  
5. Kumar, A., Srivastava, K., Kumar, S.R., Puri, S.K., Chauhan, P.M.S., Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents. Bioorg. Med. Chem. Lett. 2008;18(24):6530–6533. doi:  ­https://doi.org/­10.1016/j.bmcl.­2008.­10.049
6. Acharya, B.N., Thavaselvam, D., Kaushik, M.B. Synthesis and antimalarial evaluation of novel pyridine quinoline hybrids. Med.Chem. Res. 2008;17:487–494. Available at:  
7. Kumar, S., Bawa, S., Drabu, S., Panda, B.P., Design and synthesis of 2-chloroquinoline derivatives as non-azoles antimycotic agents. Med. Chem. Res. 2011;20(8):1340–1348. doi: https://doi.org/10.1007/s00044-010-9463-6 
8.  Modapa, S., Tusi, Z., Sridhar, D., Kumar, A., Siddiqi, M.I., Srivastava, K., Rizvi, A., Tripathi, R., Puri, S.K., Keshava, G.B.S., Shukla, P.K., Batra, S., Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides. Bioorg. Med. Chem. 2009;17(1):203–221.

doi: https://doi.org/10.1016/j.bmc.2008.11.021

1. Kovi, K.E., Yearick, K., Iwaniuk, D.P., Natarajan, J.K., Alumasa, J.,de Dois, A.C., Roepe, P.D., Wolf, C., Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides. Bioorg. Med. Chem. 2009; 17(1):270–283. doi: https://doi.org/10.1016/j.bmc.2008.11.009
2. Shashi Pandeya, Pooja Agarwalb, Kumkum Srivastavab, S. RajaKumarb, Sunil K. Purib, Pravesh Vermac, J. K. Saxenac, Abhisheak Sharmad, Jawahar Lald and Prem. M. S. Chauhana, Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivativbes as potent antimalarial agents. E. J. Med Chem. 2013;66:69-81. doi:  https://doi.org/­10.1016/j.ejmech.2013.05.023
3. Singh, B., Chetia, D., Puri, S.K., Srivastava, K., Prakash, A., Synthesis and in vitro and in vivo antimalarial activity of novel 4-anilinoquinoline Mannich base derivatives. Med. Chem. Res. 2011;20(9):1523–1529. doi: https://doi.org/10.1007/s00044-010-9397-z
4. Assefa, H., Kamath, S., Buolamwini, J.K. 3D-QSAR and docking studies on 4-anilino­quinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. J.Comput. Aided Mol. Des. 2003;17(8):475–493. doi: https://doi.org/10.1023/B:JCAM.0000004622.13865.4f
5. Scott, D.A., Balliet, C.L., Cook, D.J., Davies, A.M., Gero, T.W., Omer, C.A., Poondru, S., Theoclitou, M.E., Tyurin, B., Zinda,M.J. Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase. Bioorg. Med. Chem.Lett. 2009; 19(3): 697–700. doi: https://doi.org/10.1016/j.bmcl.2008.12.046  
6. Mai, A., Rotili, D., Tarantino, D., Nebbioso, A., Castellano, S.,Sbardella, G., Tini, M., Altucci, L. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyl­transferases. Bioorg. Med. Chem. Lett. 2009;19(4):1132–1135. doi: https://doi.org/­10.1016/­j.bmcl.2008.12.097
7. Miller, L.M., Mayer, S.C., Berger, D.M., Boschelli, D.H., Boschelli,F., Di, L., Du, X., Dutia, M., Floyd, M.B., Johnson, M., Kenny,C.H., Krishnamurthy, G., Moy, F., Petusky, S., Tkach, D., Torres, N., Wu, B., Xu, W. Lead identification to generate 3-cyano­quinoline inhibitors of insulin-like growth factor receptor(IGF-1R) for potential use in cancer treatment. Bioorg. Med.Chem. Lett. 2009;19(1):62–66.doi:https://doi.org/10.1016­/­j.bmcl.2008.11.037
8. Chen, S., Chen, R., He, M., Pang, R., Tan, Z., Yang, M. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat–TAR interaction inhibitors. Bioorg.Med.Chem.2009;17(5):1948–1956. doi:  https://doi.org/10.1016/­j.bmc.­2009.01.038
9. Wang, Y., Ai, J., Wang, Y., Chen, Y., Wang, L., Liu, G., Geng, M.,Zhang, A. Synthesis and c-Met kinase inhibition of 3,5-disubstituted and 3,5,7-trisubstituted quinolines: identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7-(trifluoro­methyl)­qui­no­line as a novel anticancer agent.J. Med.Chem.2011;54(7):2127–2142. doi:  https:/­/doi.org/10.1021/jm101340q
10. Marganakop, S.B., Kamble, R.R., Taj, T., Kariduraganvar, M.Y. An efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatized with 1,3,4-thiadiazole as anticancer and anti-tubercular agents. Med. Chem. Res. 2012;21(2):185–191. doi: https://doi.org/10.107/s00044-010-9522-z
11. Upadhayaya, R.S., Vandavasi, J.K., Vasireddy, N.R., Sharma, V., Dixit, S.S., Chattopadhyaya, J., Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis. Bioorg. Med. Chem. 2009;17(7):2830–2841. doi:  https://doi.org/10.1016/j.bmc.2009.02.026
12. Souza M.V.N.D., Pais K.C., Kaiser C.R., Peralta M.A., Ferreira M.D.L., Lourenco M.C.S., Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. Bioorg. Med. Chem. 2009;17(4):1474–1480. doi: https://doi.org/10.1016/j.bmc.2009.01.013
13. Lilienkampf A., Mao J., Wan B., Wang Y., Franzblau S.G., Kozikowski A.P. Structure activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating mycobacterium tuberculosis. J. Med. Chem. 2009;52(7):2109–2118. doi: https://doi.org/10.1021/jm900003c
14. Eswaran S., Adhikari A.V., Chowdhury I.H., Pal N.K., Thomas K.D., New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties. Eur.J.Med.Chem.2010;45(8):3374–3383.doi: https://doi.org/10.1016/j.ejmech.2010.04.022
15. Shivaraj Y., Malenahalli H. N., Giriyapura R., Kumar V., and Doyijode B., Kumar A. Design, Synthesis and Antibacterial Activity Studies of Novel Quinoline Carboxamide Derivatives.Journal of the Korean Chemical Society 2013;57(2):241-245 doi: https:/­/doi.org­/10.5012/jkcs.2013.57.2.241
16. Hanane F., Abdellah Ech-Chahad, Abdeslam Lamiri. New Synthesis and Biological Screening of some Pyrrolo Quinoline Derivatives. CODEN (USA): 2014;6(1);63-69.  Available at:  http://sphinxsai.com/2014/PharmTech/PDF/PT=09(63-69)JM14.pdf
17. Mehul M. P. and Laxman J. P. Design, Synthesis, Molecular Docking, and Antibacterial Evaluation of Some Novel Flouroquinolone Derivatives as Potent Antibacterial Agent. The Scientific World Journal. 2014; Article ID 897187, 10 pages. doi: http://dx.doi.org/­10.1155/2014/897187

ԲՈՎԱՆԴԱԿՈՒԹՅՈՒՆ

Ներածություն

Գրական ակնարկ

Հետազոտման նյութեր և մեթոդներ

Ստացված արդյունքների  քննարկում

Փորձնական մաս

Եզրակացություններ

Գրականություն